claudio cuello (22 Ergebnisse)

Hardcover. Zustand: Very Good. No Jacket. Missing dust jacket; May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.

Zustand: New. pp. 511.

Hardback. Zustand: Very Good. Series: Progress in Brain Research. xxii 462p large format hardback, blue cloth with black and red jacket, very good condition, binding tight, a little wear to jacket edges, pages clean and neat, no marks or annotations, all photographs and diagrams clear and sharp, a good copy Language: English Weight (g): 1429.

Zustand: very good. Cuello, D. (illustrator). Gut/Very good: Buch bzw. Schutzumschlag mit wenigen Gebrauchsspuren an Einband, Schutzumschlag oder Seiten. / Describes a book or dust jacket that does show some signs of wear on either the binding, dust jacket or pages.

Hardcover. Zustand: Très bon. Ancien livre de bibliothèque avec équipements. Edition 1995. Ammareal reverse jusqu'à 15% du prix net de cet article à des organisations caritatives. ENGLISH DESCRIPTION Book Condition: Used, Very good. Former library book. Edition 1995. Ammareal gives back up to 15% of this item's net price to charity organizations.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Zustand: Sehr gut. Zustand: Sehr gut | Seiten: 340 | Sprache: Englisch | Produktart: Bücher | Alzheimer¿s disease is a serious health concern in developed countries where the population is progressively aging. At the personal level the diagnosis of the disease represents a devastating scenario for both the sufferer and care givers. In recent years medications have been developed that mitigate somewhat the symptoms and delay, for a while, the progression of the disease. It is expected that in the coming years new medications will be developed that are capable of halting the chain of pathological events and symptoms of the disease. This book covers a wide range of the pharmacological mechanism underlying present and potential new therapies. The recent extraordinary advances in our understanding of the cell and molecular biology of Alzheimer¿s disease allows for an optimistic forecast of innovative therapies. This book will be of value to a wide audience interested in cellular and molecular mechanisms leading to the pathology of Alzheimer¿s disease and on the multiple, possible, therapeutic opportunities ahead of us. The field of research is enormous and therefore therapeutic targets that have been selected for this volume seem the most hopeful and for which there is a solid rationale. There are a number of emerging therapeutic targets, such as the inactivation/removal of Aß peptides, amongst others, which might have potential applications if specific leading compounds were to be identified.

Zustand: Sehr gut. Zustand: Sehr gut | Seiten: 484 | Sprache: Englisch | Produktart: Bücher | Keine Beschreibung verfügbar.

Zustand: Used. pp. xx + 324 Illus.

Zustand: Used. pp. xx + 324.

Paperback. Zustand: Brand New. 544 pages. 9.61x6.69x1.10 inches. In Stock.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This volume arose from the scientific program of the XIIth International Congress of Pharmacology, held in Montreal, Canada, July 24-29, 1994. The scientific program included plenary lectures and symposia, in addition to poster presentations and colloquia. The abstracts of the Congress presentations were published as .supplement 1 of volume 72 by the Cana dian Journal of Physiology & Pharmacology. The Congress organizers sought a more expansive treatment of the Congress proceedings and appointed Dr. A. Claudio Cuello to coordinate preparation of the present volume; Dr. Brian Collier was chair of the scientific program committee and, thus, also collaborated on this work. The objective that we pursued was to produce a volume of reasonable size which would feature all of the plenary lectures and symposia from those authors who agreed to participate. To this end, we solicited mini reviews from plenary lecturers and asked symposia organizers to coordi nate a single short-review covering the individual topics within their event. Those who accepted this challenge are evident in this volume. We express our gratitude to these authors for doing so, and for exercising considerable ingenuity in completing their task within a reasonable time.

Gebunden. Zustand: New.

Zustand: New.

Buch. Zustand: Neu. Neuware -Alzheimer¿s disease is a serious health concern in developed countries where the population is progressively aging. At the personal level the diagnosis of the disease represents a devastating scenario for both the sufferer and care givers. In recent years medications have been developed that mitigate somewhat the symptoms and delay, for a while, the progression of the disease. It is expected that in the coming years new medications will be developed that are capable of halting the chain of pathological events and symptoms of the disease. This book covers a wide range of the pharmacological mechanism underlying present and potential new therapies. The recent extraordinary advances in our understanding of the cell and molecular biology of Alzheimer¿s disease allows for an optimistic forecast of innovative therapies.This book will be of value to a wide audience interested in cellular and molecular mechanisms leading to the pathology of Alzheimer¿s disease and on the multiple, possible, therapeutic opportunities ahead of us. The field of research is enormous and therefore therapeutic targets that have been selected for this volume seem the most hopeful and for which there is a solid rationale. There are a number of emerging therapeutic targets, such as the inactivation/removal of Aß peptides, amongst others, which might have potential applications if specific leading compounds were to be identified.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 340 pp. Englisch.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Alzheimer's disease is a serious health concern in developed countries where the population is progressively aging. At the personal level the diagnosis of the disease represents a devastating scenario for both the sufferer and care givers. In recent years medications have been developed that mitigate somewhat the symptoms and delay, for a while, the progression of the disease. It is expected that in the coming years new medications will be developed that are capable of halting the chain of pathological events and symptoms of the disease. This book covers a wide range of the pharmacological mechanism underlying present and potential new therapies. The recent extraordinary advances in our understanding of the cell and molecular biology of Alzheimer's disease allows for an optimistic forecast of innovative therapies. This book will be of value to a wide audience interested in cellular and molecular mechanisms leading to the pathology of Alzheimer's disease and on the multiple, possible, therapeutic opportunities ahead of us. The field of research is enormous and therefore therapeutic targets that have been selected for this volume seem the most hopeful and for which there is a solid rationale. There are a number of emerging therapeutic targets, such as the inactivation/removal of Aß peptides, amongst others, which might have potential applications if specific leading compounds were to be identified.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Alzheimer's disease is a serious health concern in developed countries where the population is progressively aging. At the personal level the diagnosis of the disease represents a devastating scenario for both the sufferer and care givers. In recent years medications have been developed that mitigate somewhat the symptoms and delay, for a while, the progression of the disease. It is expected that in the coming years new medications will be developed that are capable of halting the chain of pathological events and symptoms of the disease. This book covers a wide range of the pharmacological mechanism underlying present and potential new therapies. The recent extraordinary advances in our understanding of the cell and molecular biology of Alzheimer's disease allows for an optimistic forecast of innovative therapies. This book will be of value to a wide audience interested in cellular and molecular mechanisms leading to the pathology of Alzheimer's disease and on the multiple, possible, therapeutic opportunities ahead of us. The field of research is enormous and therefore therapeutic targets that have been selected for this volume seem the most hopeful and for which there is a solid rationale. There are a number of emerging therapeutic targets, such as the inactivation/removal of Aß peptides, amongst others, which might have potential applications if specific leading compounds were to be identified.

Zustand: New.

Hardcover. Zustand: Brand New. 1st edition. 319 pages. 9.50x6.25x1.00 inches. In Stock.

Hardcover. Zustand: Brand New. 350 pages. 10.31x7.56x0.87 inches. In Stock.

Zustand: New.